Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionChicago Capital, LLC
Latest Disclosed Ownership1,460 shares
Latest Disclosed Value $ 223,082
Chicago Capital, LLC ownership in NVS / Novartis AG - Depositary Receipt (Common Stock)

On April 23, 2026 - Chicago Capital, LLC filed a 13F-HR form disclosing ownership of 1,460 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $223,015 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 1,460 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 0.00% during the quarter. The current value of the position is $209,744 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-23 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 1,460 0 0.00 223 10.95 0.0060
2026-01-26 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 1,460 1,460 201 0.0050
2025-10-22 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 0 -2,113 -100.00 0 -100.00
2025-07-17 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 2,113 -25 -1.17 256 7.14 0.0063
2025-04-17 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 2,138 2,138 238 0.0067
2025-01-24 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 0 -2,830 -100.00 0 -100.00
2024-10-18 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 2,830 190 7.20 326 15.66 0.0090
2024-08-06 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 2,640 0 0.00 281 10.20 0.0084
2024-04-15 2024-03-31 13F NOVARTIS SPONSORED ADR 66987V109 2,640 0 0.00 255 -4.14 0.0078
2024-01-22 2023-12-31 13F NOVARTIS SPONSORED ADR 66987V109 2,640 0 0.00 267 -0.75 0.0096
2023-10-25 2023-09-30 13F NOVARTIS SPONSORED ADR 66987V109 2,640 0 0.00 269 0.75 0.0126
2023-07-20 2023-06-30 13F NOVARTIS SPONSORED ADR 66987V109 2,640 0 0.00 266 9.92 0.0120
2023-04-18 2023-03-31 13F NOVARTIS SPONSORED ADR 66987V109 2,640 0 0.00 243 1.26 0.0121
2023-01-20 2022-12-31 13F NOVARTIS SPONSORED ADR 66987V109 2,640 -750 -22.12 240 -7.36 0.0132
2022-10-14 2022-09-30 13F NOVARTIS SPONSORED ADR 66987V109 3,390 0 0.00 258 -10.10 0.0149
2022-07-21 2022-06-30 13F NOVARTIS SPONSORED ADR 66987V109 3,390 0 0.00 287 -3.37 0.0159
2022-04-21 2022-03-31 13F NOVARTIS SPONSORED ADR 66987V109 3,390 0 0.00 297 0.00 0.0128
2022-01-20 2021-12-31 13F NOVARTIS SPONSORED ADR 66987V109 3,390 750 28.41 297 37.50 0.0111
2021-10-28 2021-09-30 13F NOVARTIS SPONSORED ADR 66987V109 2,640 0 0.00 216 -10.37 0.0082
2021-07-22 2021-06-30 13F NOVARTIS SPONSORED ADR 66987V109 2,640 0 0.00 241 6.64 0.0094
2021-04-13 2021-03-31 13F NOVARTIS SPONSORED ADR 66987V109 2,640 0 0.00 226 -9.24 0.0095
2021-01-25 2020-12-31 13F NOVARTIS SPONSORED ADR 66987V109 2,640 0 0.00 249 8.26 0.0111
2020-10-13 2020-09-30 13F NOVARTIS SPONSORED ADR 66987V109 2,640 0 0.00 230 -0.43 0.0118
2020-07-29 2020-06-30 13F NOVARTIS SPONSORED ADR 66987V109 2,640 0 0.00 231 5.96 0.0134
2020-04-21 2020-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 2,640 0 0.00 218 -12.80 0.0176
2020-01-14 2019-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 2,640 -262 -9.03 250 -0.79 0.0153
2019-10-28 2019-09-30 13F NOVARTIS AG SPONSORED ADR NAMENAKTIE 66987V109 2,902 0 0.00 252 -4.91 0.0169
2019-07-11 2019-06-30 13F NOVARTIS AG SPONSORED ADR NAMENAKTIE 66987V109 2,902 -50 -1.69 265 -6.69 0.0170
2019-04-23 2019-03-31 13F NOVARTIS AG SPONSORED ADR NAMENAKTIE 66987V109 2,952 0 0.00 284 12.25 0.0193
2019-02-11 2018-12-31 13F NOVARTIS A G SPONSORED ADR NAMENAKTIE 66987V109 2,952 -100 -3.28 253 -3.80 0.0206
2018-11-02 2018-09-30 13F NOVARTIS A G SPONSORED ADR SPONSORED ADR 66987V109 3,052 -180 -5.57 263 7.79 0.0182
2018-07-19 2018-06-30 13F NOVARTIS A G SPONSORED ADR NAMENAKTIE 66987V109 3,232 3,232 244 0.0197
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.